Mannatech (NASDAQ:MTEX) Now Covered by StockNews.com

Stock analysts at StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEX) in a report issued on Monday. The brokerage set a “buy” rating on the stock.

Mannatech Price Performance

Mannatech stock opened at $7.50 on Monday. The company has a market cap of $14.14 million, a P/E ratio of -8.43 and a beta of 1.17. Mannatech has a 1-year low of $6.75 and a 1-year high of $11.80. The company has a fifty day simple moving average of $7.37 and a 200 day simple moving average of $7.71. The company has a current ratio of 1.17, a quick ratio of 0.62 and a debt-to-equity ratio of 0.54.

Mannatech (NASDAQ:MTEX) last released its earnings results on Tuesday, August 13th. The company reported ($0.33) earnings per share for the quarter. The business had revenue of $27.74 million during the quarter. Mannatech had a negative net margin of 0.97% and a negative return on equity of 11.87%.

Insider Activity

In other news, Director Larry A. Jobe sold 16,288 shares of Mannatech stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $7.75, for a total value of $126,232.00. Following the completion of the transaction, the director now owns 54,721 shares of the company’s stock, valued at approximately $424,087.75. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 41.50% of the company’s stock.

About Mannatech

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.